Alexander Schornstein

Alexander Schornstein discloses dealings in 2 companies, chiefly Assembly Biosciences, Inc. and Lite Strategy, Inc. Between 20 November 2023 and 18 December 2025, the trades on record add up to 10 filings.

On the open market, the record shows 9 purchases worth €1.3M and 1 sale worth €806k. On balance, insiders were net buyers of €462k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2025 alone, the filings show no purchases and 1 sale.

In size, the median ticket on the buying side is €133k. None of the 7 purchases we analysed coincided with buying by another insider of the same company within 30 days. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 57% of cases, with a median move of +5.5%. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 22 December 2025: an open-market sale of €806k, in Lite Strategy, Inc. The clock since the last published purchase (26 November 2024) now reads 712 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.